Amarin (Nasdaq: AMRN) made perhaps the biggest splash in the small-cap biopharmaceutical space last year by announcing trial results from its long-running REDUCE-IT study. The company has a market cap … [Read more...] about Amarin Corporation – A Whale of a Story
You must be logged in to post a comment.